Daiwa Securities Group’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-469
| Closed | – | – | 1310 |
|
|
2023
Q3 | $0 | Hold |
469
| – | – | ﹤0.01% | 1281 |
|
|
2023
Q2 | $0 | Hold |
469
| – | – | ﹤0.01% | 1309 |
|
|
2023
Q1 | $1K | Hold |
469
| – | – | ﹤0.01% | 1228 |
|
|
2022
Q4 | $1K | Hold |
469
| – | – | ﹤0.01% | 1246 |
|
|
2022
Q3 | $1K | Sell |
469
-18,409
| -98% | -$39.3K | ﹤0.01% | 1255 |
|
|
2022
Q2 | $32K | Sell |
18,878
-16,638
| -47% | -$28.2K | ﹤0.01% | 1093 |
|
|
2022
Q1 | $73K | Buy |
35,516
+11,001
| +45% | +$22.6K | ﹤0.01% | 1069 |
|
|
2021
Q4 | $92K | Buy |
24,515
+9,133
| +59% | +$34.3K | ﹤0.01% | 1015 |
|
|
2021
Q3 | $80K | Buy |
15,382
+15,126
| +5,909% | +$78.7K | ﹤0.01% | 1007 |
|
|
2021
Q2 | $1K | Hold |
256
| – | – | ﹤0.01% | 1169 |
|
|
2021
Q1 | $1K | Hold |
256
| – | – | ﹤0.01% | 1178 |
|
|
2020
Q4 | $1K | Buy |
+256
| New | +$1K | ﹤0.01% | 1154 |
|
|
2019
Q4 | – | Sell |
-323
| Closed | – | – | 1186 |
|
|
2019
Q3 | $0 | Hold |
323
| – | – | ﹤0.01% | 1164 |
|
|
2019
Q2 | $1K | Hold |
323
| – | – | ﹤0.01% | 1151 |
|
|
2019
Q1 | $1K | Hold |
323
| – | – | ﹤0.01% | 1142 |
|
|
2018
Q4 | $2K | Hold |
323
| – | – | ﹤0.01% | 1087 |
|
|
2018
Q3 | $4K | Hold |
323
| – | – | ﹤0.01% | 1072 |
|
|
2018
Q2 | $4K | Hold |
323
| – | – | ﹤0.01% | 1090 |
|
|
2018
Q1 | $4K | Buy |
+323
| New | +$4K | ﹤0.01% | 1074 |
|